FMF Unit, Department of Medicine, Hadassah University Hospital, Jerusalem, Israel Correspondence to: Dr E Ben-Chetrit, Department of Medicine A, Hadassah University Hospital, PO Box 12 000, Jerusalem, ...
Although MTX was initially introduced as a chemotherapeutic agent for the treatment of malignancies, it is clear that, in the doses used, the mechanism of action in the suppression of inflammation ...